Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000537860 | SCV000626182 | benign | Fanconi anemia | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000537860 | SCV002534981 | likely benign | Fanconi anemia | 2021-06-23 | criteria provided, single submitter | curation | |
Revvity Omics, |
RCV003144133 | SCV003833900 | uncertain significance | Fanconi anemia complementation group A | 2022-03-09 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003477509 | SCV004221996 | uncertain significance | not provided | 2024-10-21 | criteria provided, single submitter | clinical testing | The FANCA c.308C>T (p.Ser103Leu) variant has been reported in the published literature in a family identified as high risk for breast and/or ovarian cancer (PMID: 27153395 (2016)). The frequency of this variant in the general population, 0.00055 (11/19934 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. |
ITMI | RCV000120950 | SCV000085118 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |